As per the recent research analysis, the Global Body Composition Analyzers (BCAs) Market size was worth USD 539.1 million in 2019 and is projected to be growing at a CAGR of 13.23%, to touch USD 1003.4 million by 2024 during the forecast period 2019 - 2024.
Body composition stands for the proportion of fat and fat-free mass present in the body. It is used to describe the percentages of fat, bone, water and muscle in human bodies. Body Composition Analyzers (BCAs) are used to measure body composition.
Healthy body composition refers to the one that includes a lower proportion of body fat and a higher proportion of fat-free or lean mass. Since muscular tissue takes up lesser space in the body when compared to fat tissue, leanness is determined by the bodyweight as well as body composition. Body Composition Analyzers (BCAs) not only determine body composition but also aid in determining the risk of an individual to develop diseases like truncal and abdominal obesity.
The growth of the Global Body Composition Analyzers (BCAs) Market is majorly driven by the increasing consciousness of people towards health and fitness. Furthermore, rising obese populace, increasing utility of these analyzers in the sports and fitness industry and the growing government initiatives to encourage fitness consciousness and physical activity among people, are expected to be the drivers of market growth.
However, the high cost of the equipment and the inaccuracy of various analyzers are some of the constraints faced by the market.
REPORT COVERAGE
|
Report Metric |
Details |
|
Market Size Available |
2018 – 2024 |
|
Base Year |
2018 |
|
Forecast Period |
2019 – 2024 |
|
Segments Analysed |
By Product, End User, and Region |
|
Regions Analysed |
North America, Europe, Asia Pacific, Latin America, Middle East and Africa |
|
Companies Analysed |
InBody Co., Ltd (South Korea), Tanita Corporation (Japan), Omron Corporation (Japan), Hologic, Inc. (U.S.) and GE Healthcare. |
This research report on the Global Body Composition Analyzers (BCAs) Market has been segmented and sub-segmented into the following categories and calculated market size and forecast for each segment until 2024.
Body Composition Analyzers (BCAs) Market - By Product:
Body Composition Analyzers (BCAs) Market - By End User:
Regional Analysis:
As of 2018, North America leads the market, accounting for the major global market share, owing to the deeper technology integration and market access. Europe comes in second in terms of market share. However, Asia-Pacific is expected to expand at the highest CAGR during the forecast period majorly because of the increasing health and fitness awareness among a huge population base and rising disposable incomes.
Key market participants leading the Global Body Composition Analyzers (BCAs) Market profiled in this report are:
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Product
5.1.1 Introduction
5.1.2 Bio-Impedance Analyzers
5.1.3 Dual Energy X-Ray Absorptiometry Equipment
5.1.4 Skinfold Callipers
5.1.5 Air Displacement Plethysmography
5.1.6 Hydrostatic Weighing Equipment
5.1.5 Y-o-Y Growth Analysis, By Product
5.1.6 Market Attractiveness Analysis, By Product
5.1.7 Market Share Analysis, By Product
5.2 End User
5.2.1 Introduction
5.2.2 Hospitals
5.2.3 Fitness Clubs and Wellness Centres
5.2.4 Academic & Research Centres
5.2.5 Home Users
5.2.6 Y-o-Y Growth Analysis, By End User
5.2.7 Market Attractiveness Analysis, By End User
5.2.8 Market Share Analysis, By End User
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Product
6.1.3.3 By End User
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Product
6.1.4.3 By End User
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Product
6.1.5.3 By End User
6.2 North America
6.1.1 Introduction
6.1.2 United States
6.1.3 Canada
6.3 Europe
6.2.1 Introduction
6.2.2 U.K
6.2.3 Spain
6.2.4 Germany
6.2.5 Italy
6.2.6 France
6.4 Asia-Pacific
6.3.1 Introduction
6.3.2 China
6.3.3 India
6.3.4 Japan
6.3.5 Australia
6.3.6 South Korea
6.5 Latin America
6.4.1 Introduction
6.4.2 Brazil
6.4.3 Argentina
6.4.4 Mexico
6.4.5 Rest of Latin America
6.6 Middle East & Africa
6.5.1 Introduction
6.5.2 Middle-East
6.5.3 Africa
7.Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 InBody Co.
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Tanita Corporation
8.3 Omron Corporation
8.4 Hologic
8.5 GE Healthcare
9.Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
Feb 2020
Download Sample
Feb 2020
Download Sample
Feb 2020
Download Sample
Feb 2020
Download Sample
